Log in to save to my catalogue

Pitavastatin protects against neomycin-induced ototoxicity through inhibition of endoplasmic reticul...

Pitavastatin protects against neomycin-induced ototoxicity through inhibition of endoplasmic reticul...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f5e5c13afb4b418cb25f4dd1e005a9fd

Pitavastatin protects against neomycin-induced ototoxicity through inhibition of endoplasmic reticulum stress

About this item

Full title

Pitavastatin protects against neomycin-induced ototoxicity through inhibition of endoplasmic reticulum stress

Publisher

Lausanne: Frontiers Research Foundation

Journal title

Frontiers in molecular neuroscience, 2022-08, Vol.15, p.963083-963083

Language

English

Formats

Publication information

Publisher

Lausanne: Frontiers Research Foundation

More information

Scope and Contents

Contents

Irreversible injury to inner ear hair cells induced by aminoglycoside antibiotics contributes to the formation of sensorineural hearing loss. Pitavastatin (PTV), a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, has been reported to exert neuroprotective effects. However, its role in aminoglycoside-induced hearing loss remains unknown. T...

Alternative Titles

Full title

Pitavastatin protects against neomycin-induced ototoxicity through inhibition of endoplasmic reticulum stress

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f5e5c13afb4b418cb25f4dd1e005a9fd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f5e5c13afb4b418cb25f4dd1e005a9fd

Other Identifiers

ISSN

1662-5099

E-ISSN

1662-5099

DOI

10.3389/fnmol.2022.963083

How to access this item